• Fluconazole in Fungal Viability Assays

  2026-10-01

  A scenario-driven guide to using Fluconazole (SKU B2094) in fungal viability, proliferation, susceptibility, and resistance studies. It connects mechanism, solvent preparation, assay controls, strain-specific interpretation, and practical product-selection criteria to improve experimental consistency.

• Risedronate Sodium in Reliable Cell Assays

  2026-10-01

  Learn how Risedronate Sodium (SKU A5293) can support reproducible viability, uptake, and apoptosis workflows through mechanism-aware dosing, water-based preparation, and careful interpretation of formulation data. The article connects bone metabolism research with emerging pulmonary applications while separating documented evidence from practical recommendations.

• LY294002 Workflow for PI3K Signaling Studies

  2026-09-30

  Build reproducible PI3K/Akt experiments with LY294002, from dose-finding and phosphoprotein readouts to apoptosis and autophagy assays. The workflow also shows how to interpret LY294002 in neuroinflammation models while controlling for cytotoxicity and BET bromodomain activity.

• Indomethacin A8449: Practical Lab Workflow

  2026-09-30

  Indomethacin (SKU A8449) provides a defined small-molecule tool for comparing COX-1 and COX-2 inhibition while monitoring possible PPAR and membrane-state effects in research assays. This guide covers solvent selection, assay controls, storage, and interpretation limits; it is not a substitute for validated clinical or in vivo use.

• PDHA1 Succinylation and Immune Escape in Cholangiocarcinoma

  2026-09-29

  This 2025 study identifies PDHA1 lysine 83 succinylation as a metabolic switch that promotes α-ketoglutaric acid accumulation, suppresses macrophage antigen presentation, and supports immune escape in cholangiocarcinoma. It further shows that pharmacologic targeting with CPI-613 can improve gemcitabine–cisplatin activity, providing a mechanistic framework for studying chemotherapy resistance.

• ARCA EGFP mRNA: Mechanism and Workflow

  2026-09-29

  ARCA EGFP mRNA is a direct-detection reporter for measuring delivery and protein expression in mammalian cells. Its ARCA cap, approximately 100-nucleotide poly(A) tail, and EGFP fluorescence support a practical mRNA transfection control workflow.

• HOBt in Amide Bond Formation: A Route-Design Lens

  2026-09-28

  HOBt (1-Hydroxybenzotriazole) is more than a peptide coupling additive: it can shape stereochemical control, active-ester chemistry, and medicinal-chemistry route design. This article examines its mechanistic value through the synthesis of indazole-based glucagon receptor antagonists.

• ALC-0159 and the Missing Layer in mRNA Imaging

  2026-09-28

  ALC-0159 is a PEG-conjugated lipid excipient for mRNA lipid nanoparticles, not an imaging reporter. This article explains how to interpret PET measurements of encoded antigen expression without confusing particle distribution, protein production, and vaccine activity.

• Olaparib (AZD2281) in DNA Damage Research

  2026-09-27

  Use Olaparib to connect PARP inhibition with measurable DNA-damage phenotypes—and, in carefully designed models, test how repair stress shapes tumor immune responsiveness. This workflow emphasizes BRCA1-versus-BRCA2 comparisons, controlled combination experiments, and practical checks for solvent, timing, and assay interpretation.

• Patient-Derived Gastric Cancer Assembloids in Context

  2026-09-26

  This study developed patient-specific gastric cancer assembloids by combining tumor organoids with matched stromal cell subpopulations. The co-cultures retained epithelial and stromal features and showed gene-expression and drug-response differences from organoid monocultures, highlighting the importance of tumor context when interpreting preclinical screens.

• Ruxolitinib Phosphate: Reliable JAK/STAT Assays

  2026-09-25

  A practical guide to using Ruxolitinib phosphate (SKU A3781) in cell viability, proliferation, and cytotoxicity workflows. It connects JAK1/2 potency and formulation data with assay design, interpretation, and evidence from an anaplastic thyroid cancer study.

• Pronase E Workflows for TNBC Ferroptosis Research

  2026-09-25

  Use Pronase E as a controlled limited-proteolysis tool to probe protein accessibility and support target-engagement assays—not as a component of gramine’s reported anticancer mechanism. This practical workflow separates protease-treated samples from intact-protein and ferroptosis readouts, helping protect interpretation of the CUL3–MTDH axis.

• Spatial Kidney Assembloids Improve Disease Modeling

  2026-09-24

  Huang et al. developed mouse and human kidney progenitor assembloids that organize nephron and collecting-system progenitors in a spatial arrangement resembling kidney development. The models show improved cellular complexity and maturation, and in vivo-grown PKD2-deficient human assembloids reproduce key features of polycystic kidney disease and its multicellular interactions.

• Parathyroid hormone (1-34) (human) in CKD assays

  2026-09-24

  Use this defined PTH fragment to probe receptor signaling and test how endothelial responses may connect to CKD-associated valvular calcification. The workflow pairs rapid cAMP readouts with longer EndMT and endothelial–interstitial-cell experiments, while keeping proposed conditions distinct from published findings.

• LINC01977 Super-Enhancer Hijacking in Early LUAD

  2026-09-23

  Zhang et al. describe a reciprocal circuit in which tumor-associated macrophage-associated TGF-β signaling activates the LINC01977 super-enhancer, while LINC01977 promotes SMAD3-dependent transcription and malignant behavior in lung adenocarcinoma. The findings connect enhancer regulation, immune context, and transcriptional coactivation, while suggesting experiments to test this pathway rather than establishing a treatment strategy.

8419 records 1/562 page Next 12345 下5页 Last page